Clinical Trials in 2025 Face a Tug-of-War Between Innovation, Costs, and Regulation 1 year ago ByJohnIn Clinical Trials
Beyond Weight Loss: GLP-1 Agonists Show Promise Across Neurological, Cardiovascular, and Renal Diseases 1 year ago ByJohnIn Breaking NewsInnovationResearch UpdatesTop Stories
FDA Awards RMAT Designation to Mesoblast’s Cell Therapy for Heart Defect, Paving the Way for Pediatric Innovation 1 year ago ByJohnIn Biopharma HighlightsFDA ApprovalsLeadersPharma Industry UpdatesTop Stories
FDA Approves First Acellular Tissue Vessel Therapy for Extremity Vascular Trauma 1 year ago ByJohnIn Clinical TrialsFDA ApprovalsResearch Updates
UK Grants Royal Assent to Major Clinical Trials Reform, Streamlining Research and Patient Access 1 year ago ByJohnIn InnovationResearch Updates
GSK’s FIRST Trial Meets Primary Endpoint: Dostarlimab Plus Niraparib Shows Progression-Free Survival Benefit in First-Line Advanced Ovarian Cancer 1 year ago ByJohnIn Breaking NewsPharma Industry UpdatesTop Stories
AI Drug Discovery Hits Milestone as First Fully Machine-Designed Molecule Enters Phase 2 1 year ago ByJohnIn AI & DataBiopharma HighlightsClinical TrialsResearch Updates
Psychedelic Therapies Edge Toward Mainstream as Phase 3 Trials Expand Globally 1 year ago ByJohnIn Breaking NewsClinical TrialsFDA Approvals
FDA Approves First MSC Therapy for Pediatric GvHD as PepGen Faces Clinical Hold in DMD Trial 1 year ago ByJohnIn Clinical TrialsFDA Approvals
Lepu Biopharma Licenses T-Cell Engagers to Excalipoint in $857M Deal, Expanding China’s Immunotherapy Footprint 1 year ago ByJohnIn PartnershipsPeopleTop StoriesVenture Capital
Dexcom Unveils AI-Enhanced Glucose Monitor for OTC Use, Pushing FDA Boundaries 1 year ago ByJohnIn BreakthroughsClinical TrialsFDA Approvals
Cellarity’s AI-Designed Cell Therapy Enters Phase 1 for Solid Tumors, Backed by $250M Series D 1 year ago ByJohnIn Biopharma HighlightsClinical TrialsInvestmentsVenture Capital
Pragmatic Trials, Real-World Impact: NIH’s 2024 Push to Redefine Clinical Research 1 year ago ByJohnIn BreakthroughsFeatured AnalysisLeadersTop Stories
FDA Approves Depemokimab for Severe Eosinophilic Asthma: A Win for Rare Disease Innovation 1 year ago ByJohnIn BreakthroughsFDA ApprovalsPharma Industry Updates
mRNA-Based RSV Vaccine Shows Strong Efficacy in Older Adults: Moderna’s Candidate Advances Toward Approval 1 year ago ByJohnIn Biopharma HighlightsBreaking NewsClinical Trials
